echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hutchison Whampoa declares third-generation BTK inhibitor

    Hutchison Whampoa declares third-generation BTK inhibitor

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 27, the CDE official website showed that Hutchison Whampoa submitted a clinical application for the BTK inhibitor HMPL-760 capsule and was accepted
    .

    According to official information, HMPL-760 is a third-generation BTK inhibitor with the ability to reversibly and non-covalently bind wild-type and C481S mutant BTK
    .
    In animal experiments, HMPL-760 has a stronger binding force than ibrutinib and ARQ-531, and has the potential to be used in combination with the PI3Kδ inhibitor HMPL-689 and the CD47 monoclonal antibody HMPL-A83


    .


    Now in China, BTK inhibitors can be called PD-1 in the field of chemical drugs, and 18 domestic projects and 8 imported drug projects have entered the clinical stage
    .
    In the first half of 2021 alone, 4 new projects were approved for clinical trials, and 3 new projects started clinical trials


    .


    However, there are few domestic R&D projects for the third-generation BTK inhibitors.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.